EvelynOrlandoMD
Internal Medicine • New York, NYInternal Medicine Resident, New York Presbyterian-Columbia
Dr. Orlando is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 W 168th St
Rm 205
New York, NY 10032Phone+1 212-305-6354
Education & Training
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2020 - 2023
New York Medical CollegeClass of 2020, MD
Tufts UniversityBS, Biopsychology , 2009 - 2013
Certifications & Licensure
NY State Medical License 2023 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Alpha Omega Alpha Honor Medical Society 2019
- Gold Humanism Honors Society 2019
Publications & Presentations
PubMed
- 3 citationsEBV Reactivation and Lymphomagenesis: More Questions than Answers.Maegan Ford, Evelyn Orlando, Jennifer Effie Amengual
Current Hematologic Malignancy Reports. 2023-12-01 - 3 citationsPilot Trial of Homebound Hematopoietic Cell Transplantation.Heather J Landau, Evelyn Orlando, Elizabeth S Rodriguez, Allison Applebaum, Hannah-Rose Mitchell
Transplantation and Cellular Therapy. 2022-12-01 - 19 citationsCD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma.Eric L. Smith, Sean M. Devlin, Satyajit Kosuri, Evelyn Orlando, Heather Landau
Biology of Blood and Marrow Transplantation. 2016-02-01
Abstracts/Posters
- Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed ...Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; Petrovic, V.; Williams, L.; Orlando,..., Blood/ASH 2016, San Diego, CA, 12/2/2016
- Targeting Wilms' tumor 1 protein following CD34-selected allografts by adoptive transfer of donor-derived CTLs in patients with advanced multiple myelomaKoehne, G.; Kosuri, S.; Doubrovina, E. S.; Orlando, E.; Giralt, S. A.; Jungbluth, A. A.; O'Reilly, R. J., Biology of Blood and Marrow Transplantation/2016 BMT Tandem Meetings, Honolulu, HI, 2/18/2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
